A Phase 1 Single and Multiple-Dose Study of Aramchol in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

September 30, 2009

Study Completion Date

October 31, 2009

Conditions
Healthy
Interventions
DRUG

Aramchol

1.Aramchol in 16 healthy male subjects at single doses ranging between 30 and 900 mg (Part A) and in 30 overweight, mildly hypercholesterolemic, otherwise healthy male subjects receiving multiple doses (Part B)

DRUG

Aramchol

Oral Aramchol at dose 30 mg to 900 mg

DRUG

Aramchol

Oral Aramchol at doses 30 mg to 900 mg single dose and 30 mg and high dose for 4 days

Trial Locations (1)

64239

Tasmc Clinical Research Center, Tel Aviv

Sponsors
All Listed Sponsors
lead

Galmed Medical Reserch

INDUSTRY